246 related articles for article (PubMed ID: 34990024)
21. Lopinavir/ritonavir: a review of its use in the management of HIV infection.
Cvetkovic RS; Goa KL
Drugs; 2003; 63(8):769-802. PubMed ID: 12662125
[TBL] [Abstract][Full Text] [Related]
22. Polypharmacy and drug-drug interactions in older and younger people living with HIV: the POPPY study.
Halloran MO; Boyle C; Kehoe B; Bagkeris E; Mallon P; Post FA; Vera J; Williams I; Anderson J; Winston A; Sachikonye M; Sabin C; Boffito M
Antivir Ther; 2019; 24(3):193-201. PubMed ID: 30700636
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of possible drug-drug interactions between antiretroviral agents in different age groups in a section of the private health care sector setting in South Africa.
Katende-Kyenda NL; Lubbe MS; Serfontein JH; Truter I
J Clin Pharm Ther; 2008 Aug; 33(4):393-400. PubMed ID: 18613857
[TBL] [Abstract][Full Text] [Related]
24. Drug-drug interactions: antiretroviral drugs and recreational drugs.
Staltari O; Leporini C; Caroleo B; Russo E; Siniscalchi A; De Sarro G; Gallelli L
Recent Pat CNS Drug Discov; 2014; 9(3):153-63. PubMed ID: 25429704
[TBL] [Abstract][Full Text] [Related]
25. Development of an evidence evaluation and synthesis system for drug-drug interactions, and its application to a systematic review of HIV and malaria co-infection.
Seden K; Gibbons S; Marzolini C; Schapiro JM; Burger DM; Back DJ; Khoo SH
PLoS One; 2017; 12(3):e0173509. PubMed ID: 28334018
[TBL] [Abstract][Full Text] [Related]
26. Analysis of Clinical Drug-Drug Interaction Data To Predict Magnitudes of Uncharacterized Interactions between Antiretroviral Drugs and Comedications.
Stader F; Kinvig H; Battegay M; Khoo S; Owen A; Siccardi M; Marzolini C
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29686151
[TBL] [Abstract][Full Text] [Related]
27. Analysis of drug-drug interactions among patients receiving antiretroviral regimens using data from a large open-source prescription database.
Patel N; Borg P; Haubrich R; McNicholl I
Am J Health Syst Pharm; 2018 Aug; 75(15):1132-1139. PubMed ID: 29903710
[TBL] [Abstract][Full Text] [Related]
28. Potential or contraindicated drug-drug interactions with antiretroviral therapy in real-world settings in Taiwan.
Wang CC; Li HJ; Shao CH; Sheng WH
J Formos Med Assoc; 2022 Sep; 121(9):1714-1720. PubMed ID: 34961668
[TBL] [Abstract][Full Text] [Related]
29. Assessment of drug-drug interaction in an elderly human immunodeficiency virus population: Comparison of 3 expert databases.
Ruellan AL; Bourneau-Martin D; Joyau C; Secher S; Fialaire P; Hitoto H; Leautez S; Michau C; Vatan R; Billaud E; Briet M; Jolliet P; Raffi F; Allavena C
Br J Clin Pharmacol; 2021 Mar; 87(3):1194-1202. PubMed ID: 32696528
[TBL] [Abstract][Full Text] [Related]
30. Drug-drug Interactions in Patients with HIV and Cancer in Sub-Saharan Africa.
Strope JD; Lochrin SE; Sissung TM; Kem R; Chandrasekaran P; Sharon E; Price DK; Uldrick TS; Yarchoan R; Figg WD
AIDS Rev; 2020 Oct; 23(1):13-27. PubMed ID: 33105469
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and nature of potential drug-drug interactions among hospitalized HIV patients presenting with suspected meningitis in Uganda.
Eneh PC; Hullsiek KH; Kiiza D; Rhein J; Meya DB; Boulware DR; Nicol MR
BMC Infect Dis; 2020 Aug; 20(1):572. PubMed ID: 32758158
[TBL] [Abstract][Full Text] [Related]
32. Management of anticoagulation in patients with human immunodeficiency virus/acquired immunodeficiency virus.
Sabourin AA; Patel T; Saad S; Renner E; Mouland E; Adie S; Ha NB
Thromb Res; 2021 Apr; 200():102-108. PubMed ID: 33571723
[TBL] [Abstract][Full Text] [Related]
33. Antiretroviral therapy, immune suppression and renal impairment in HIV-positive persons.
Ryom L; Mocroft A; Lundgren JD
Curr Opin HIV AIDS; 2014 Jan; 9(1):41-7. PubMed ID: 24225381
[TBL] [Abstract][Full Text] [Related]
34. The road to success. Long-term prognosis for persons living with HIV in Denmark - time trends and risk factors.
Lohse N
Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836803
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic interactions of modern antiretroviral therapy.
Sinxadi PZ; Khoo SH; Boffito M
AIDS; 2021 Dec; 35(Suppl 2):S145-S151. PubMed ID: 34848581
[TBL] [Abstract][Full Text] [Related]
36. Burden of Exposure to Potential Interactions Between Antiretroviral and Non-Antiretroviral Medications in a Population of HIV-Positive Patients Aged 50 Years or Older.
Ranzani A; Oreni L; Agrò M; van den Bogaart L; Milazzo L; Giacomelli A; Cattaneo D; Gervasoni C; Ridolfo AL
J Acquir Immune Defic Syndr; 2018 Jun; 78(2):193-201. PubMed ID: 29767640
[TBL] [Abstract][Full Text] [Related]
37. Population pharmacokinetic modelling to quantify the magnitude of drug-drug interactions between amlodipine and antiretroviral drugs.
Courlet P; Guidi M; Alves Saldanha S; Cavassini M; Stoeckle M; Buclin T; Marzolini C; Decosterd LA; Csajka C
Eur J Clin Pharmacol; 2021 Jul; 77(7):979-987. PubMed ID: 33452585
[TBL] [Abstract][Full Text] [Related]
38. Renal dysfunction among HIV-infected patients starting antiretroviral therapy.
Msango L; Downs JA; Kalluvya SE; Kidenya BR; Kabangila R; Johnson WD; Fitzgerald DW; Peck RN
AIDS; 2011 Jul; 25(11):1421-5. PubMed ID: 21572304
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of diabetes mellitus and hypertension in people living with human immunodeficiency virus on antiretroviral therapy in Gweru district, Zimbabwe.
Gonah L; Moodley I; Hlongwana K
Afr J Prim Health Care Fam Med; 2020 Aug; 12(1):e1-e6. PubMed ID: 32787407
[TBL] [Abstract][Full Text] [Related]
40. Management of drug interactions with direct-acting antivirals in Dutch HIV/hepatitis C virus-coinfected patients: adequate but not perfect.
Smolders EJ; Smit C; de Kanter C; Dofferhoff A; Arends JE; Brinkman K; Rijnders B; van der Valk M; Reiss P; Burger DM;
HIV Med; 2018 Mar; 19(3):216-226. PubMed ID: 29194939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]